MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation

Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune rejection because they are derived from a patient's own cells without ethical concerns. These cells can be used in regenerative medical...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stem cell reviews and reports Ročník 14; číslo 1; s. 71 - 81
Hlavní autoři: Zeng, Zhao-Lin, Lin, Xiao-Long, Tan, Li-Lan, Liu, Ya-Mi, Qu, Kai, Wang, Zuo
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Springer Nature B.V 01.02.2018
Témata:
Animals
Cell Differentiation - genetics
Cell Differentiation - physiology
Drug development
Drug discovery
Embryo cells
Ethics
Humans
Induced Pluripotent Stem Cells - cytology
Induced Pluripotent Stem Cells - metabolism
MicroRNAs
MicroRNAs - genetics
MicroRNAs - physiology
miRNA
Pluripotency
Stem cells
Therapeutic applications
Transcription factors
Induced pluripotent stem cell
Generation
MicroRNA
Differentiation
ISSN:2629-3269, 2629-3277, 2629-3277
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune rejection because they are derived from a patient's own cells without ethical concerns. These cells can be used in regenerative medical techniques, stem cell therapy, disease modelling and drug discovery investigations. However, this application faces many challenges, such as low efficiency, slow generation time, partially reprogrammed colonies and tumourigenicity. Numerous techniques have been formulated in the past decade to improve reprogramming efficiency and safety, including the use of different transcription factors, small molecule compounds and non-coding RNAs. Recently, microRNAs (miRNAs) were found to promote the generation and differentiation of iPS cells. The miRNAs can more effectively and safely generate iPS cells than transcription factors. This process ultimately leads to the development of iPSC-based therapeutics for future clinical applications. In this comprehensive review, we summarise advances in research and the application of iPS cells, as well as recent progress in the use of miRNAs for iPS cell generation and differentiation. We examine possible clinical applications, especially in cardiology.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
ISSN:2629-3269
2629-3277
2629-3277
DOI:10.1007/s12015-017-9785-6